Antiangiogenic strategies in epithelial ovarian cancer: mechanism, resistance, and combination therapy
C Jin, M Yuan, H Bu, C Jin - Journal of Oncology, 2022 - Wiley Online Library
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
C Jin, M Yuan, H Bu, C Jin - Journal of Oncology, 2022 - search.proquest.com
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
[PDF][PDF] Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
C Jin, M Yuan, H Bu, C Jin - 2022 - scienceopen.com
1. Background Ovarian cancer is one of the most lethal gynecological malignancies [1]. In
2021, there will be approximately 21,410 new ovarian cancer cases diagnosed and 13,770 …
2021, there will be approximately 21,410 new ovarian cancer cases diagnosed and 13,770 …
[HTML][HTML] Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
C Jin, M Yuan, H Bu, C Jin - Journal of Oncology, 2022 - ncbi.nlm.nih.gov
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy.
C Jin, M Yuan, H Bu - Journal of Oncology, 2022 - europepmc.org
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
C Jin, M Yuan, H Bu, C Jin - Journal of oncology, 2022 - pubmed.ncbi.nlm.nih.gov
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy.
C Jin, M Yuan, H Bu, C Jin - Journal of Oncology, 2022 - search.ebscohost.com
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …
and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved …